Defense Contractor Northrop Grumman (NOC) Hits 52-Week Low at $470

Key Takeaways

• Northrop Grumman (NOC) shares sank to a 52-week low of $470.06, settling near $476.45 with a roughly 1% decline.
• RBC Capital Markets lowered its rating from Outperform to Sector Perform while reducing the price target from $640 to $525.
• Wall Street maintains a consensus “Moderate Buy” rating with an average target price of $647.57.
• The company exceeded Q2 expectations with adjusted EPS of $7.68 compared to the $6.82 consensus and revenue rising 5% to $10.88 billion.
• Concerns center on defense budget deceleration beyond fiscal 2027 and minimal international revenue opportunities.

Shares of Northrop Grumman (NOC) plunged to their lowest point in a year this week. The stock briefly hit $470.06 before recovering slightly to close around $476.45, marking approximately a 1% loss.

Northrop Grumman Corporation, NOC

The decline followed a downgrade issued by RBC Capital Markets. The investment firm shifted its stance on the aerospace and defense giant from Outperform to Sector Perform.

Alongside the rating change, RBC dramatically lowered its price objective. The target now stands at $525, representing a significant cut from the previous $640 mark.

In a research note distributed to investors, analyst Ken Herbert outlined projections for approximately 6% yearly revenue expansion spanning 2026 through 2028. He characterized this forecast as an optimistic outlook comparable to competitor performance.

Key Factors Behind the Rating Cut

Herbert highlighted Northrop’s minimal presence in overseas markets as a significant weakness. He also raised red flags about anticipated budget growth deceleration following fiscal year 2027, which may restrict the stock’s appreciation potential.

The recent F/A-XX fighter jet contract award went to Boeing. However, Herbert observed that market participants hadn’t anticipated Northrop securing that particular program, so the outcome didn’t materially impact the downgrade decision.

Looking forward, RBC believes revenue expansion hinges on several critical initiatives. Among these are the B-21 stealth bomber program, aerospace ventures, and possibly solid rocket motor development.

Successful execution of these programs will require substantial capital commitments. RBC’s financial model incorporates an assumption of only modest real defense spending increases in the low single digits between 2028 and 2031.

The analyst cautioned about escalating “crowding out” concerns within defense appropriations during this timeframe. While Herbert expects core initiatives to maintain funding support, he identified rising vulnerability for the F-35 program, which represents approximately 10% of total revenues.

Share repurchase strategy also factored into the analysis. Herbert pointed out that the company reduced its outstanding share count by half during the decade from 2007 to 2017, and more conservative buyback policies ahead could dampen investor sentiment and constrain per-share earnings growth.

Regarding the B-21 bomber platform, RBC anticipates the program’s scope expanding to a minimum of 150 aircraft as mission requirements broaden. Nevertheless, the analyst continues to view this initiative as creating short-term margin pressure.

Financial Performance and Valuation

The downgrade notwithstanding, the broader analyst community maintains a generally bullish outlook on NOC. The stock holds a consensus “Moderate Buy” recommendation, with a mean price objective of $647.57—substantially above where shares currently trade.

Among Wall Street professionals tracking the company, two assign Strong Buy ratings, ten recommend Buy, and nine suggest Hold. This distribution reflects diverging views following recent adjustments to targets in both directions.

The company’s most recent quarterly results, disclosed on July 21st, surpassed analyst estimates. Northrop delivered adjusted earnings per share of $7.68, topping the $6.82 consensus forecast.

Quarterly sales reached $10.88 billion, reflecting a 5% year-over-year increase and exceeding the $10.80 billion projection. However, EPS declined compared to the prior-year period’s $8.15 figure.

Management has issued full-year 2026 EPS guidance in the $28.60 to $29.10 range. The Street’s current consensus of $28.97 falls squarely within that target window.

The company distributes a $2.47 quarterly dividend, translating to roughly a 2.1% annual yield. Technical indicators show the 50-day moving average at $538.98 and the 200-day average at $568.95—both significantly higher than the current market price.